| PERIOD ENDING | 30-Apr-09 | 30-Apr-08 | 30-Apr-07 | | Total Revenue | 4,049 | 4,772 | 2,531 | | Cost of Revenue | 4,840 | 7,960 | 3,984 | | | Gross Profit | (791) | (3,188) | (1,452) | | | Operating Expenses | | Research Development | 8,372 | 8,255 | 6,220 | | Selling General and Administrative | 9,529 | 7,733 | 4,894 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (18,692) | (19,176) | (12,566) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 377 | 4,519 | 2,927 | | Earnings Before Interest And Taxes | (18,315) | (14,657) | (9,639) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (18,315) | (14,657) | (9,639) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (18,315) | (14,657) | (9,639) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (18,315) | (14,657) | (9,639) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($18,315) | ($14,657) | ($9,639) |
|
1.48% Nasdaq 
Income Statement
